Citicoline in the Treatment of Cognitive Impairment

  • Secades J
N/ACitations
Citations of this article
36Readers
Mendeley users who have this article in their library.

Abstract

Vascular cognitive impairment is a process which is more frequent in patients with cardiovascular risk factors. The etiology of this kind of impairment could be related to different types of cerebrovascular disorders, given that silent cerebral infarctions or microinfarcts, correlated with small vessel disease, are one of the principal etiologies. Microinfarcts, associated with small vessel diseases, should be considered one of the possible causes of clinical suspicion in patients with cardiovascular risk factors who are asking for help for cognitive complaints. Among the proposed treatments for cognitive impairment there is citicoline. This is an updated review of the possible use of citicoline in the treatment of cognitive impairment.

Cite

CITATION STYLE

APA

Secades, J. J. (2019). Citicoline in the Treatment of Cognitive Impairment. Journal of Neurology and Experimental Neuroscience, 05(01). https://doi.org/10.17756/jnen.2019-047

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free